With over 50 years of combined experience, DVCR’s cGMP compliant compounding pharmacy is capable of handling and manipulating study drugs for various routes of administration. Learn...
At Dr. Vince Clinical Research, we utilize a forward-thinking model for Phase I studies supported by foundational pillars that completely reimagine research standards. Every inch of our facilities, and every step in our procedures, is intentionally designed, enabled...
CROs have a retention problem. Nearly 1 in 5 research sites have a turnover rate above 30%, and it has become increasingly difficult for many facilities and site management organizations to build a robust roster of specialized and proven professionals (1). While the...
OVERLAND PARK, KS, December 12, 2022 (Globe Newswire) – Dr. Vince Clinical Research (DVCR) announced the addition of highly experienced investigator George J. Atiee, M.D. to the medical team at its world-class clinical pharmacology unit. Dr. Atiee has been practicing...
OVERLAND PARK, Kan.; November 8, 2022 (ACCESSWIRE) – Dr. Vince Clinical Research (DVCR), a world-class early phase contract research organization (CRO) specializing in the conduct of Phase I clinical trials, today announced that it has administered the first dose in...
Recent Comments